AXON THERAPIES INC has a total of 15 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets medical technology are NOVASYS MEDICAL INC, CIBIEM INC and IOWA APPROACH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Electrotherapy | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Gelfand Mark | 14 |
#2 | Panescu Dorin | 12 |
#3 | Levin Howard | 10 |
#4 | Engelman Zoar Jacob | 9 |
#5 | Leung Mark S | 8 |
#6 | Wu Andrew | 7 |
#7 | Engelman Zoar | 4 |
#8 | Leung Mark | 4 |
#9 | Miller Casey Andrew | 1 |
#10 | Mcgrath Thomas Ryan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020257763A1 | Methods and devices for endovascular ablation of a splanchnic nerve | |
CA3089217A1 | Methods and devices for endovascular ablation of a splanchnic nerve | |
WO2019118976A1 | Methods and devices for endovascular ablation of a splanchnic nerve | |
WO2018023132A1 | Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation | |
US2018110561A1 | Devices and methods for treatment of heart failure by splanchnic nerve ablation |